Search Results - "Leung, Roland C Y"

Initial experience with the Oncotype DX assay in decision-making for adjuvant therapy of early oestrogen receptor-positive breast cancer in Hong Kong by Cheung, Polly S Y, Tong, Adam C, Leung, Roland C Y, Kwan, W H, Yau, Thomas C C

“…To examine the impact of the 21-gene Oncotype DX Breast Cancer Assay on the adjuvant treatment decision-making process for early-stage breast cancer in Hong…”
Get full text

The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong by Leung, Roland C.Y., Yau, Thomas C.C., Chan, Miranda C.M., Chan, Sharon W.W., Chan, Terence W.C., Tsang, Yvonne Y.Y., Wong, Ting Ting, Chao, Calvin, Yoshizawa, Carl, Soong, Inda S., Kwan, Wing-Hong, Kwok, Carol C.H., Suen, Joyce S.J., Ngan, Roger K.C., Cheung, Polly S.Y.

“…We evaluated the impact of the Oncotype DX assay on adjuvant treatment decisions for Chinese patients with breast cancer in Hong Kong. A comparison of…”
Get full text

Current management of pregnancy-associated breast cancer by Yu, H Hy, Cheung, P Sy, Leung, R Cy, Leung, T N, Kwan, W H

“…Pregnancy-associated breast cancer is the most common malignancy during pregnancy with an expected rise in incidence. The belief in the need for termination of…”
Get full text

Regression of BRAF V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases by Woo, Peter Y M, Lam, Tai-Chung, Pu, Jenny K S, Li, Lai-Fung, Leung, Roland C Y, Ho, Jason M K, Zhung, James T F, Wong, Belinda, Chan, Timonthy S K, Loong, Herbert H F, Ng, Ho-Keung

“…Up to 15% of young adults with glioblastoma have the activating oncogenic mutation, an actionable target of the MAPK signal transduction pathway governing…”
Get full text

Thyroid Immune-Related Adverse Events Among Cancer Patients Treated With Combination of Anti-PD1 and Anti-CTLA4 Immune-Checkpoint Inhibitors: Clinical Course and Outcomes by Lui, David T W, Lee, Chi Ho, Tang, Vikki, Fong, Carol H Y, Lee, Alan C H, Chiu, Joanne W Y, Leung, Roland C Y, Kwok, Gerry G W, Li, Bryan C W, Cheung, Tan To, Woo, Yu Cho, Lam, Karen S L, Yau, Thomas

“…Abstract Introduction: Thyroid immune-related adverse events (irAEs) have been reported to have prognostic significance among cancer patients treated with…”
Get full text

The Impact of the Onco type DX® Breast Cancer Assay on Treatment Decisions for Women with Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong by Leung, Roland CY, Yau, Thomas CC, Chan, Miranda CM, Chan, Sharon WW, Chan, Terence WC, Tsang, Yvonne YY, Wong, Ting Ting, Chao, Calvin, Yoshizawa, Carl, Soong, Inda S, Kwan, Wing-Hong, Kwok, Carol CH, Suen, Joyce SJ, Ngan, Roger KC, Cheung, Polly SY

“…Abstract Background The Onco type DX® Breast Cancer Assay is validated to assess risk of distant recurrence and likelihood of chemotherapy (CT) benefit in ER+…”
Get full text

Regression of BRAF V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases by Woo, Peter Y M, Lam, Tai-Chung, Pu, Jenny K S, Li, Lai-Fung, Leung, Roland C Y, Ho, Jason M K, Zhung, James T F, Wong, Belinda, Chan, Timonthy S K, Loong, Herbert H F, Ng, Ho-Keung

“…BACKGROUNDUp to 15% of young adults with glioblastoma have the activating oncogenic BRAF V600E mutation, an actionable target of the MAPK signal transduction…”
Get full text